Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer.
OBJECTIVE
Transcription factor zinc finger E-box-binding homeobox 1 (ZEB1), as one of the key inducers of epithelial-mesenchymal transition, has been reported to be regulated by microRNA-144 and Bcl-2-associated athanogene 3, which both promote thyroid cancer cell invasion. However, the involvement of ZEB1 in thyroid cancer has not been fully elucidated. In this study, we aimed to investigate the role and clinical implication of ZEB1 in this disease.


METHODS
Immunohistochemistry was performed to examine the subcellular localization and the expression level of ZEB1 protein in 82 self-pairs of formalin-fixed and paraffin-embedded cancerous and adjacent noncancerous tissues obtained from patients with thyroid cancer. The roles of ZEB1 in thyroid cancer cell migration, invasion, and proliferation were also detected by transwell and MTT analyses, respectively.


RESULTS
Immunohistochemistry showed that ZEB1 was predominantly localized in the nucleus of thyroid cancer cells. Its immunoreactive score in thyroid cancer tissues was significantly higher than that in adjacent noncancerous tissues (P=0.01). In addition, ZEB1 overexpression was significantly associated with the advanced tumor node metastasis staging (P=0.008), the positive lymph node metastasis (P=0.01) and distant metastasis (P=0.02). Furthermore, ZEB1 knockdown by siRNA could efficiently inhibit the migration, invasion, and proliferation abilities of thyroid cancer cells in vitro.


CONCLUSIONS
These findings indicated that ZEB1 might function as an oncogene, the overexpression of which was associated with the aggressive tumor progression of human thyroid cancer. Interestingly, ZEB1 also could promote thyroid cancer cell migration, invasion, and proliferation, suggesting that the inhibition of this protein might be a therapeutic strategy for the treatment of this malignancy.
Department of General Surgery, Navy General Hospital of Chinese PLA, Beijing, People's Republic of China.
Yan
Y
Zhang
Department of General Surgery, Navy General Hospital of Chinese PLA, Beijing, People's Republic of China.
Gang
G
Liu
Department of General Surgery, Navy General Hospital of Chinese PLA, Beijing, People's Republic of China.
Shihe
S
Wu
Department of General Surgery, Navy General Hospital of Chinese PLA, Beijing, People's Republic of China.
Futing
F
Jiang
Department of General Surgery, Navy General Hospital of Chinese PLA, Beijing, People's Republic of China.
Jiangping
J
Xie
Department of General Surgery, Navy General Hospital of Chinese PLA, Beijing, People's Republic of China.
Yuhong
Y
Wang
immunohistochemistry; invasion; migration; proliferation; small interfering RNA; thyroid cancer; zinc finger E-box-binding homeobox 1